TIM
LAB icon

Thompson Investment Management’s Standard BioTools LAB Stock Holding History

Thompson Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-16,200
Closed -$65K – 179
2017
Q2 		$65K Hold
16,200
– – 0.01% 176
2017
Q1 		$92K Hold
16,200
– – 0.02% 176
2016
Q4 		$118K Hold
16,200
– – 0.02% 176
2016
Q3 		$130K Hold
16,200
– – 0.03% 176
2016
Q2 		$146K Hold
16,200
– – 0.03% 170
2016
Q1 		$131K Hold
16,200
– – 0.03% 169
2015
Q4 		$175K Hold
16,200
– – 0.04% 167
2015
Q3 		$131K Buy
+16,200
New +$255K 0.03% 165
2015
Q2 		– Sell
-7,200
Closed -$303K – 171
2015
Q1 		$303K Hold
7,200
– – 0.06% 140
2014
Q4 		$243K Buy
+7,200
New +$204K 0.05% 154

Other funds holding LAB

LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return